Cite
PREDICTORS OF ONE-YEAR VISUAL OUTCOMES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
MLA
Kodjikian, Laurent, et al. “Predictors of One-Year Visual Outcomes After Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration.” Retina (Philadelphia, Pa.), vol. 38, no. 8, Aug. 2018, pp. 1492–99. EBSCOhost, https://doi.org/10.1097/IAE.0000000000001736.
APA
Kodjikian, L., Decullier, E., Souied, E. H., Roux, A., Aulagner, G., & Huot, L. (2018). Predictors of One-Year Visual Outcomes After Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration. Retina (Philadelphia, Pa.), 38(8), 1492–1499. https://doi.org/10.1097/IAE.0000000000001736
Chicago
Kodjikian, Laurent, Evelyne Decullier, Eric H Souied, Adeline Roux, Gilles Aulagner, and Laure Huot. 2018. “Predictors of One-Year Visual Outcomes After Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration.” Retina (Philadelphia, Pa.) 38 (8): 1492–99. doi:10.1097/IAE.0000000000001736.